Celularity Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Celularity Inc. (CELU) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 33.41 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-04-30
- Celularity Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 15.85M shares, a 4.47% increase year-over-year.
- Celularity Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 15.17M shares, a 31.50% increase year-over-year.
- Celularity Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-09-30 was 106.91M shares, a 94.15% increase year-over-year.
- Celularity Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-06-30 was 88.47M shares, a 98.60% increase year-over-year.
- Celularity Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 33.41M shares, a 96.04% increase from fiscal 2024.
- Celularity Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 17.04M shares, a 51.30% increase from fiscal 2023.
- Celularity Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 11.26M shares, a 110.82% increase from fiscal 2022.
- Celularity Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 5.34M shares, a 92.33% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 33.41M shares 10-K · filed 2026-04-30 | |||||||
| 2025-09-30 | 21.31M shares 10-Q · filed 2025-11-14 | |||||||
| 2025-06-30 | 17.31M shares 10-Q · filed 2025-08-29 | |||||||
| 2025-03-31 | 15.85M shares 10-Q · filed 2025-08-29 | |||||||
| 2024-12-31 | 17.04M shares 10-K · filed 2026-04-30 | |||||||
| 2024-09-30 | 15.96M shares 10-Q · filed 2025-11-14 | 15.93M shares 10-Q · filed 2024-12-06 | ||||||
| 2024-06-30 | 15.07M shares 10-Q · filed 2025-08-29 | |||||||
| 2024-03-31 | 15.17M shares 10-Q · filed 2025-08-29 | |||||||
| 2023-12-31 | 11.26M shares 10-K · filed 2025-05-08 | |||||||
| 2023-09-30 | 106.91M shares 10-Q · filed 2024-01-03 | 13.74M shares 10-Q · filed 2024-12-06 | 139.67M shares 10-Q · filed 2024-01-03 | |||||
| 2023-06-30 | 88.47M shares 10-Q · filed 2023-08-14 | 11.81M shares 10-Q · filed 2024-11-07 | 119.03M shares 10-Q · filed 2023-08-14 | |||||
| 2023-03-31 | 11.54M shares 10-Q · filed 2024-10-16 | 115.31M shares 10-Q · filed 2023-05-22 | ||||||
| 2022-12-31 | 5.34M shares 10-K · filed 2024-07-30 | 53.43M shares 10-K · filed 2023-03-31 | ||||||
| 2022-09-30 | 55.06M shares 10-Q · filed 2024-01-03 | 65.85M shares 10-Q · filed 2024-01-03 | ||||||
| 2022-06-30 | 44.55M shares 10-Q · filed 2023-08-14 | 61.26M shares 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | 53.92M shares 10-Q · filed 2023-05-22 | |||||||
| 2021-12-31 | 69.69M shares 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | 11.47M shares 10-Q · filed 2022-11-10 | 71.18M shares 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | 162.17M shares 10-Q · filed 2022-08-09 | 162.17M shares 10-Q · filed 2022-08-09 | 21.38M shares 10-Q · filed 2021-08-19 | |||||
| 2021-03-31 | 156.12M shares 10-Q · filed 2022-05-16 | 21.38M shares 10-Q · filed 2021-05-24 | ||||||
| 2020-12-31 | 119.62M shares 10-K · filed 2022-03-31 | 21.38M shares 10-K · filed 2021-03-04 | ||||||
| 2020-09-30 | 120.48M shares 10-Q · filed 2021-11-12 | 120.48M shares 10-Q · filed 2021-11-12 | 21.38M shares 10-Q · filed 2020-11-16 | |||||
| 2020-06-30 | 21.38M shares 10-Q · filed 2020-08-13 | |||||||
| 2020-03-31 | 21.38M shares 10-Q · filed 2020-05-15 | |||||||
| 2019-12-31 | 21.38M shares 10-K · filed 2020-03-24 | |||||||
| 2019-09-30 | 21.38M shares 10-Q · filed 2019-11-13 | |||||||
| 2019-06-30 | 21.38M shares 10-Q · filed 2019-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |